Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cartigenix HP
- Development stage
- Unknown
- Lead developer
- Calroy Health Sciences
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Cartigenix HP is a proprietary botanical dietary supplement developed by Calroy Health Sciences, LLC, designed to support joint health and cartilage metabolism. It features a patent-pending blend called RestorCel, which consists of standardized extracts of Boswellia serrata (Indian frankincense) and wild celery seed (Apium graveolens). The formulation is standardized to specific bioactive constituents, including boswellic acids, serratol, tirucallic acids, apiin, bergapten, and seselin. It targets inflammatory pathways and biomarkers of cartilage degradation to alleviate symptoms of osteoarthritis, such as pain and stiffness, and to promote cartilage regeneration. Clinical studies have demonstrated its efficacy in improving physical function and reducing pain scores in patients with osteoarthritis.
- Brand names
- Cartigenix HP
- Other names
- RestorCel
02
Targets
Eicosanoid synth (Eicosanoid biosynthesis)
Beyond the preview
Go deeper on Cartigenix HP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cartigenix HP.